Efficacy and Safety of 3% Minoxidil Lotion for Beard Enhancement

NCT02275832 — Phase 4, Completed, 48 participants, Mae Fah Luang University Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Efficacy and Safety of 3% Minoxidil Lotion for Beard Enhancement : A Randomized, Double-blind, Placebo-controlled Study

RegistryNCT02275832
StatusCompleted
PhasePhase 4
Study typeInterventional; randomized, parallel, masking: quadruple, treatment
Enrollment48 (Actual)
SponsorMae Fah Luang University Hospital (Other)
ConditionsBeard Enhancement
Interventions3 % Minoxidil lotion, Placebo (Drug)
Datesstart 2014-11-01, primary completion 2015-03-01, completion 2015-03-01, first posted 2014-10-27, last updated 2015-04-22
Locations1 site in Thailand

Related Papers Related Patents Related Grants Related Experts
All trials for Beard Enhancement All trials of 3 % Minoxidil lotion All trials of Placebo

-Summary

The purpose of this study is to determine efficacy and safety of 3% minoxidil lotion for beard enhancement.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
MinoxidilExperimentalDrug: 3 % Minoxidil lotion3% Minoxidil lotion is applied twice daily to the beard.
PlaceboPlacebo comparatorDrug: PlaceboPlacebo is applied twice daily to beard.
  • 3 % Minoxidil lotion (Drug)
  • Placebo (Drug)

+Outcome measures

Primary outcomes

  • The change of global photographic assessment after 16 weeks from baseline [baseline and 16 weeks]

Secondary outcomes

  • The change in number of hairs after 16 weeks from baseline [baseline and 16 weeks]

Other outcomes

  • The change of hair diameter after 16 weeks from baseline [baseline and 16 weeks]
  • Number of participants with adverse events [baseline and 16 weeks]
  • Patient satisfaction by self-assessment questionnaires [baseline and 16 weeks]

+Eligibility

Sex: Male, ages: 18 Years to 60 Years, accepts healthy volunteers

Inclusion Criteria:

* Healthy male

Exclusion Criteria:

* serious underlying diseases.
* history of beard/ hair treatment before 6 months
* history of surgery or trauma on beard area.
* history of minoxidil allergy

+Locations (1)

FacilityCityCountryStatus
MFL University Hospital (Bangkok)BangkokThailand

+Publications

  • Results publication: Lee S, Tanglertsampan C, Tanchotikul M, Worapunpong N. Minoxidil 2% lotion for eyebrow enhancement: a randomized, double-blind, placebo-controlled, spilt-face comparative study. J Dermatol. 2014 Feb;41(2):149-52. doi: 10.1111/1346-8138.12275. Epub 2013 Nov 8. PMID 24471459
  • Results publication: Suwanchatchai W, Tanglertsampan C, Pengsalae N, Makornwattana M. Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study. J Dermatol. 2012 Oct;39(10):865-6. doi: 10.1111/j.1346-8138.2012.01579.x. Epub 2012 May 17. No abstract available. PMID 22594928
  • Results publication: Tanglertsampan C. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study. J Med Assoc Thai. 2012 Oct;95(10):1312-6. PMID 23193746

+Investigators